• 
• http://www.scibx.com
• Editor: Karen Bernstein
• Volume 2: 50 issues per year
• ISSN:
• EISSN: 1945-3477
• Date Established: January 2008
• Published on behalf of: NPG and BioCentury Publications, Inc.

Aims and Scope: SciBX is a publishing collaboration that brings together the business intelligence of BioCentury and the scientific acumen of Nature Publishing Group. Designed to evaluate science in a business context, SciBX filters, analyzes and identifies new research approaches and technology.

Published weekly, each issue of SciBX provides a timely, comprehensive and understandable analysis of the most commercially promising science and technology and it enhances the efficiency and speed of transfer of science from bench to bedside. Evaluating high impact peer-reviewed scientific articles each week, SciBX highlights the most commercially relevant findings that merit deeper analysis. This multidisciplinary approach provides scientific context, identifies potential commercial impact and describes the next steps required to translate th newest developments in the lab into innotvative healthcare solutions.

Readership: SciBX is a must read publication for Offices of Technology Transfer and all academic and corporate scientists and executives interested in enhancing the commercialization of life science. The publication is also an indispensable resource for biotechnology and pharmaceutical executives, business development specialists, drug discovery and development teams, venture capitalists and other investment professionals who wish to identify new projects and potential new partners, find enabling technology and scan their environment for disruptive competitive advances.

Online features and site license access:

• Online archive available back to January 2008.
• A site license provides access to all content published during the supply period. Access is granted to the complete archive during the supply period.
• A PDF subscription model is also available for single users.